Your browser doesn't support javascript.
loading
Vincristine, Irinotecan, and Temozolomide in Patients With Relapsed/Refractory Neuroblastoma.
Zhu, Jia; Wang, Juan; Sun, Feifei; Zhen, Zijun; Chen, Tingting; Lu, Suying; Huang, Junting; Zhang, Yizhuo; Sun, Xiaofei.
Afiliação
  • Zhu J; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Wang J; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Sun F; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Zhen Z; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Chen T; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Lu S; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang J; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangzhou, China.
  • Zhang Y; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Sun X; Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Guangzhou, China.
Front Oncol ; 12: 804310, 2022.
Article em En | MEDLINE | ID: mdl-35359419

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article